Share Information & SEC Filings
This page is intended for investors and commercial partners.
Mereo BioPharma share price and SEC Filings
Whether you are a portfolio manager, analyst or retail investor, this page equips you with the insights to assess Mereo’s market position and strategic direction. Nasdaq MREO share data provides real-time information about the price of Mereo stock. Records of all SEC filings deliver on our commitment to transparency and operational discipline, while delivering value for investors.
MREO Nasdaq Share Data
| Price (USD) | $2.17 |
| Change | $-0.08 |
| Volume | 2,213,168 |
| %Change | -3.56% |
| Intraday High | $2.31 |
| 52 Week High | $3.88 |
| Intraday Low | $2.17 |
| 52 Week Low | $1.47 |
| Today's Open | 2.21 |
| Previous Close | $2.25 |
SEC Filings
| Filing Date | Form Type | Description | Filing Group | Downloads |
|---|---|---|---|---|
| 15/05/2025 | SCHEDULE 13G/A | SCHEDULE 13G/A - Description | Other | |
| 14/05/2025 | SCHEDULE 13G/A | SCHEDULE 13G/A - Description | Other | |
| 14/05/2025 | 8-K | Report of unscheduled material events or corporate event | Current Reports | |
| 13/05/2025 | 10-Q | Quarterly report which provides a continuing view of a company's financial position | Quarterly Filings | |
| 13/05/2025 | 8-K | Report of unscheduled material events or corporate event | Current Reports | |
| 12/05/2025 | SCHEDULE 13G/A | SCHEDULE 13G/A - Description | Other | |
| 08/04/2025 | ARS | An annual report to security holders | Annual Filings | |
| 08/04/2025 | DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") | Proxy Filings | |
| 04/04/2025 | SCHEDULE 13G | SCHEDULE 13G - Description | ||
| 26/03/2025 | 10-K | Annual report which provides a comprehensive overview of the company for the past year | Annual Filings |
